文献速递新发突发、热带与寄生虫病细菌感染、耐药与抗菌药物

流感住院患者血培养细菌共检出的流行率与结局(2022-2024)

Prevalence and Outcomes of Bacterial Co-detections by Blood Culture Among Children and Adults Hospitalized With Laboratory-confirmed Influenza, Influenza Hospitalization Surveillance Network, 2022-2024.
PubMed 文献 · Clin Infect Dis · 2026-01-01

整体5.2%存在至少1次细菌共检出,共检出与ICU入住和院内死亡风险升高相关,金黄色葡萄球菌和肺炎链球菌共检出均与重症相关。

要点

  • 流感住院患者中5.2%存在血培养细菌共检出,与不良院内结局相关。
  • 血培养阳性数越多,ICU入住率和院内病死率越高。
  • 金黄色葡萄球菌和肺炎链球菌共检出均与重症相关,院内病死率各22.4%。

核心结论

  • 流感住院患者中的细菌血培养共检出与不良院内结局相关,预防重症流感和细菌共感染或可降低流感相关发病和死亡。

主要发现

  • 50.8%患者至少送检1次血培养,整体5.2%存在至少1次细菌共检出。
  • 无血培养、培养阴性、1次共检出和>1次共检出患者的ICU入住率分别为9.6%、19.2%、31.2%和47.9%。
  • 上述四组院内病死率分别为1.5%、3.3%、9.4%和14.5%。
  • 培养阳性患者中22.1%为金黄色葡萄球菌共检出、7.5%为肺炎链球菌共检出,两者均与重症相关,院内病死率各22.4%。

临床怎么用

  • 对流感住院患者应关注细菌共感染风险,血培养阳性尤其多次阳性提示重症和死亡风险升高。
  • 金黄色葡萄球菌或肺炎链球菌共检出提示病情可能较重,需加强监护和评估。
  • 通过疫苗接种等措施预防重症流感和细菌共感染可能减少流感相关 morbidity 和 mortality。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Influenza predisposes individuals to bacterial co-infections, which can result in disseminated infection and bacteremia. We describe the epidemiology and outcomes of blood culture co-detections among those hospitalized with influenza over 2 influenza seasons. METHODS: We sampled individuals of all ages from FluSurv-NET, a US population-based surveillance network of persons hospitalized with laboratory-confirmed influenza, during the 2022-2023 and 2023-2024 seasons. Surveillance staff collected information on bacterial blood cultures within 3 days before or 3 days following admission. We described patient characteristics and in-hospital outcomes, stratified by culture positivity, number of positive cultures, and type of co-detection, using unweighted counts and weighted percentages to account for the complex survey design. RESULTS: Overall, 14 316 patients were included, with a median (interquartile range) age of 57 (14-74) years, 53.6% female, 52.0% non-Hispanic White, and 25.6% with ≥4 categories of underlying medical conditions. Of these, 50.8% had ≥1 blood cultures obtained and 5.2% overall had ≥1 bacterial co-detections. Intensive care unit admission occurred for 9.6%, 19.2%, 31.2%, and 47.9% among patients with no blood cultures, negative cultures, 1 co-detection, and >1 co-detection documented, respectively; in-hospital mortality occurred in 1.5%, 3.3%, 9.4%, and 14.5%, respectively. Among patients with positive cultures, 22.1% had Staphylococcus aureus and 7.5% had Streptococcus pneumoniae co-detections; both were associated with severe illness (with 22.4% in-hospital mortality each). DISCUSSION: Bacterial co-detections in persons hospitalized with influenza were associated with poor in-hospital outcomes. Efforts to prevent severe influenza and bacterial co-infections, including through vaccination, may reduce substantial morbidity and mortality from influenza.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Tenforde MW, Ujamaa D, Talbot HK, et al. Prevalence and Outcomes of Bacterial Co-detections by Blood Culture Among Children and Adults Hospitalized With Laboratory-confirmed Influenza, Influenza Hospitalization Surveillance Network, 2022-2024. Clin Infect Dis. 2026. PMID: 42161336. doi:10.1093/cid/ciag242

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。